CN101991532B - 一种自微乳组合物、一种微乳,及它们的制备方法 - Google Patents
一种自微乳组合物、一种微乳,及它们的制备方法 Download PDFInfo
- Publication number
- CN101991532B CN101991532B CN200910056437.6A CN200910056437A CN101991532B CN 101991532 B CN101991532 B CN 101991532B CN 200910056437 A CN200910056437 A CN 200910056437A CN 101991532 B CN101991532 B CN 101991532B
- Authority
- CN
- China
- Prior art keywords
- microemulsion
- self
- oleanolic acid
- emulsion composition
- cosurfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 239000004530 micro-emulsion Substances 0.000 title claims abstract description 87
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000000593 microemulsion method Methods 0.000 title description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 claims abstract description 84
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 claims abstract description 84
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 claims abstract description 84
- 229940100243 oleanolic acid Drugs 0.000 claims abstract description 84
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 claims abstract description 84
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 claims abstract description 83
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000004094 surface-active agent Substances 0.000 claims abstract description 31
- 239000004064 cosurfactant Substances 0.000 claims abstract description 27
- 238000002347 injection Methods 0.000 claims abstract description 7
- 239000007924 injection Substances 0.000 claims abstract description 7
- 239000002245 particle Substances 0.000 claims description 108
- 239000000839 emulsion Substances 0.000 claims description 94
- -1 Oleum sesami Substances 0.000 claims description 72
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 67
- 239000003921 oil Substances 0.000 claims description 31
- 235000019198 oils Nutrition 0.000 claims description 31
- 239000004359 castor oil Substances 0.000 claims description 30
- 235000019438 castor oil Nutrition 0.000 claims description 30
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 30
- 239000012071 phase Substances 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 26
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 claims description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 21
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 claims description 18
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 claims description 16
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 13
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical class CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 150000002333 glycines Chemical class 0.000 claims description 9
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 229940090044 injection Drugs 0.000 claims description 6
- 229960004756 ethanol Drugs 0.000 claims description 5
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 claims description 5
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 229940093181 glucose injection Drugs 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 9
- 239000000243 solution Substances 0.000 abstract description 6
- 241001597008 Nomeidae Species 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 238000000034 method Methods 0.000 description 37
- 239000008389 polyethoxylated castor oil Substances 0.000 description 23
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 23
- 229920002685 Polyoxyl 35CastorOil Polymers 0.000 description 22
- QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 description 22
- 239000003643 water by type Substances 0.000 description 21
- OIQOAYVCKAHSEJ-UHFFFAOYSA-N 2-[2,3-bis(2-hydroxyethoxy)propoxy]ethanol;hexadecanoic acid;octadecanoic acid Chemical compound OCCOCC(OCCO)COCCO.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O OIQOAYVCKAHSEJ-UHFFFAOYSA-N 0.000 description 17
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 229940079833 sodium oleanolate Drugs 0.000 description 4
- QNELTPKHJFMSNK-RLFONNADSA-M sodium;(4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate Chemical compound [Na+].C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C([O-])=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C QNELTPKHJFMSNK-RLFONNADSA-M 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 241000243328 Hydridae Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 241000459479 Capsula Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000002966 pentacyclic triterpenoids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910056437.6A CN101991532B (zh) | 2009-08-14 | 2009-08-14 | 一种自微乳组合物、一种微乳,及它们的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910056437.6A CN101991532B (zh) | 2009-08-14 | 2009-08-14 | 一种自微乳组合物、一种微乳,及它们的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101991532A CN101991532A (zh) | 2011-03-30 |
CN101991532B true CN101991532B (zh) | 2014-04-02 |
Family
ID=43782614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910056437.6A Expired - Fee Related CN101991532B (zh) | 2009-08-14 | 2009-08-14 | 一种自微乳组合物、一种微乳,及它们的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101991532B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784096B (zh) * | 2011-05-18 | 2016-10-12 | 上海现代药物制剂工程研究中心有限公司 | 一种积雪草酸自微乳化给药系统及其制备方法 |
CN103356480B (zh) * | 2013-07-25 | 2014-11-05 | 江苏省中医药研究院 | 一种齐墩果酸纳米混悬剂及其制备方法 |
CN105878815A (zh) * | 2016-06-24 | 2016-08-24 | 凌云 | 一种治疗冠心病的中药自微乳速释滴丸及制备方法 |
CN115607510B (zh) * | 2021-04-19 | 2024-03-08 | 泉州达浔生物科技有限公司 | 一种高浓度齐墩果酸纳米乳组合物及制备方法 |
CN114796000A (zh) * | 2022-05-27 | 2022-07-29 | 泉州达浔生物科技有限公司 | 一种齐墩果酸的微乳化组合物及其制备方法和应用 |
CN115337265B (zh) * | 2022-09-30 | 2023-11-10 | 吉林大学 | 一种兽用药品—枇杷叶提取物注射液的研制 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100386085C (zh) * | 2003-12-17 | 2008-05-07 | 昆明紫健生物技术有限公司 | 一种防治肿瘤的脂肪乳输液及生产方法 |
-
2009
- 2009-08-14 CN CN200910056437.6A patent/CN101991532B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101991532A (zh) | 2011-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101991532B (zh) | 一种自微乳组合物、一种微乳,及它们的制备方法 | |
CN101926757B (zh) | 一种难溶性药物的液体组合物及其制备方法 | |
JP3903061B2 (ja) | 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤 | |
CN102614127B (zh) | 一种白藜芦醇纳米分散体及其制备方法 | |
CN109069651A (zh) | 稳定的尼莫地平肠胃外制剂 | |
HUE035013T2 (en) | Delayed oral dosage forms containing amorphous CDDO-Me | |
AU2010312017B2 (en) | Paclitaxel/steroidal complex | |
CN101390851B (zh) | 双环醇含表面活性剂的药物组合物及其制备方法和制剂 | |
KR20140041952A (ko) | 스테로이드 복합체를 중간 담체로서 이용한 파클리탁셀의 서브마이크론 에멀젼 | |
US20230398072A1 (en) | Concentrate containing poorly soluble drug and emulsion prepared therefrom | |
CN101612121A (zh) | 紫杉醇微乳的制备方法 | |
CN103079559A (zh) | 包含胺碘酮及其盐的制剂及其制造和使用方法 | |
US20020028794A1 (en) | Megestrol acetate suspension | |
CN101810576B (zh) | 一种基于混合油的葛根素自微乳组合物及其制备方法 | |
CN101618020B (zh) | 二氢吡啶类钙离子拮抗剂的固体自乳化口服给药系统及其制备方法 | |
CN102415995A (zh) | 一种黄体酮过饱和自微乳组合物及其制备方法 | |
CN102451176B (zh) | 多西紫杉烷/类固醇复合物 | |
KR101151711B1 (ko) | 올메사르탄메독소밀 함유 자가유화 약물전달시스템 조성물 및 이의 제조방법 | |
CN114425038B (zh) | 一种20(s)-ppd脂质体乳剂复合体口服给药制剂及其制备方法和应用 | |
CN106727382A (zh) | 一种卡维地洛过饱和自微乳分散片及其制备方法 | |
CN102302470B (zh) | 一种尼群地平软胶囊 | |
CN101912362B (zh) | 一种替尼泊苷静脉注射用脂肪乳预乳化浓缩液及其制备方法 | |
CN102462691B (zh) | 一种治疗肿瘤的药物组合物及其制备方法 | |
CN105769777A (zh) | 一种艾普拉唑钠冻干粉针剂 | |
CN103169657A (zh) | 一种含灯盏花素磷脂复合物的自乳化剂及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201203 Shanghai City Harley Road, Zhangjiang hi tech Park No. 965 Room 303 Patentee after: SHANGHAI PHARMAEXPLORER Co.,Ltd. Address before: 201203 Shanghai City Harley Road, Zhangjiang hi tech Park No. 965 Room 303 Patentee before: Shanghai PharmaExplorer Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170110 Address after: 201203 Shanghai City Harley Road, Pudong New Area Zhangjiang hi tech Park No. 965, No. 3 building two floor Patentee after: SHANGHAI CHEMEXPLORER Co.,Ltd. Address before: 201203 Shanghai City Harley Road, Zhangjiang hi tech Park No. 965 Room 303 Patentee before: SHANGHAI PHARMAEXPLORER Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170612 Address after: 201203 Shanghai Zhangjiang High Tech Park of Pudong New Area Cailun Road No. 3 Building No. 302 room 720 Patentee after: XDCEXPLORER (SHANGHAI) Co.,Ltd. Address before: 201203 Shanghai City Harley Road, Pudong New Area Zhangjiang hi tech Park No. 965, No. 3 building two floor Patentee before: SHANGHAI CHEMEXPLORER Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 |